9. Monteleone P., Mascagni G, Giannini A., Genazzani A. R,
and Simoncini T. Symptoms of menopause – global prevalence, physiology and implications, Nat. Rev. Endocrinol., vol. 14.10. Okano H et al.
Japan Society of Obstetrics and Gynecology and Japan Society for Menopause and Women’s Health 2017 guidelines for hormone replacement therapy, J. Obstet. Gynaecol. Res., vol. 44, no. 8, pp. 1355–1368, Aug. 2018.11. Ortmann O., Beckermann M., Inwald E., Strowitzki T., Windler E., and Tempfer C.
Peri- and postmenopause – diagnosis and interventions interdisciplinary S3 guideline of the association of the scientific medical societies in Germany (AWMF 015/062): short version, Arch. Gynecol. Obstet., vol. 302, Jul. 2020.12. Tremollieres F.
Assessment and hormonal management of osteoporosis, Climacteric, vol. 22, no. 2.13. Ulin M., Ali M., Chaudhry Z.T., Al-Hendy A, and Yang Q.
Uterine fibroids in menopause and perimenopause, Menopause, vol. 27, no. 2, pp. 238–242, 2020.14. Xu X., Jones M. and Mishra G.D.
Age at natural menopause and development of chronic conditions and multimorbidity: results from an Australian prospective cohort., Hum. Reprod., vol. 35, no. 1, pp. 203–211, Jan. 2020, doi: 10.1093/humrep/dez259.15. Yureneva S.V. and Averkova V.G.
Menopausal vasomotor symptoms: central triggers, effectors. and new possibilities of pathogenetic therapy, Ross. Vestn. akushera-ginekologa, vol. 18, no. 5, p. 43, 2018, doi: 10.17116/rosakush20181805143.16. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society, Menopause, vol. 27.